on March 2, 2006
Published online before print March 2, 2006, doi: 10.1161/01.ATV.0000215638.53414.99
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 29, 2005
Accepted on February 15, 2006
Kruppel-Like Factor 2 Inhibits Protease Activated Receptor-1 Expression and Thrombin-Mediated Endothelial Activation
Zhiyong Lin ;
From the Program in Cardiovascular Transcriptional Biology, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.
* To whom correspondence should be addressed. E-mail: mjain{at}rics.bwh.harvard.edu.
Objective--The serine protease thrombin can dramatically alter endothelial gene expression in a manner that confers a proinflammatory phenotype. Recent studies have identified the Kruppel-like factor 2 (KLF2) as a critical regulator of endothelial gene expression. Herein, we provide evidence that KLF2 inhibits thrombin-mediated endothelial activation via alterations in expression of its principal receptor protease-activated receptor-1 (PAR-1).
Methods and Results--Forced expression of KLF2 in human umbilical vein endothelial cells potently inhibited the ability of thrombin to induce multiple prothrombotic factors (tissue factor, CD40L, plasminogen activator inhibitor-1), cytokines/chemokines (eg, monocyte chemotactic protein-1, interleukin-6 [IL-6], IL-8), and matrix degrading enzymes (eg, matrix metalloproteinases 1, 2, and 9). Mechanistically, KLF2 inhibits PAR-1 expression and, as a consequence, thrombin-mediated nuclear factor 
B (NF-B) nuclear accumulation and DNA binding. Conversely, small interfering RNA-mediated knockdown of KLF2 increases PAR-1 expression and thrombin-mediated induction of NF-B activation.
Conclusion--These studies identify KLF2 as a novel regulator of PAR-1 expression and thrombin action in endothelial cells.
Key words: Kruppel • thrombin • PAR-1 • transcription • endothelial cells
Related Article:
- Flow Perturbation Is Linked to Endothelial PAR Signaling
- Wolfram Ruf
Arterioscler. Thromb. Vasc. Biol. 2006 26: 962-964.[Full Text] [PDF]
This article has been cited by other articles:
 |
|
 |
|
  G. B. Atkins and M. K. Jain Role of Kruppel-Like Transcription Factors in Endothelial Biology Circ. Res., June 22, 2007; 100(12): 1686 - 1695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hamik, Z. Lin, A. Kumar, M. Balcells, S. Sinha, J. Katz, M. W. Feinberg, R. E. Gerszten, E. R. Edelman, and M. K. Jain Kruppel-like Factor 4 Regulates Endothelial Inflammation J. Biol. Chem., May 4, 2007; 282(18): 13769 - 13779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Methe, M. Balcells, M. del Carmen Alegret, M. Santacana, B. Molins, A. Hamik, M. K. Jain, and E. R. Edelman Vascular bed origin dictates flow pattern regulation of endothelial adhesion molecule expression Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2167 - H2175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Boon, J. O. Fledderus, O. L. Volger, E. J.A. van Wanrooij, E. Pardali, F. Weesie, J. Kuiper, H. Pannekoek, P. ten Dijke, and A. J.G. Horrevoets KLF2 Suppresses TGF-{beta} Signaling in Endothelium Through Induction of Smad7 and Inhibition of AP-1 Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 532 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hirano The Roles of Proteinase-Activated Receptors in the Vascular Physiology and Pathophysiology Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 27 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Thum and J. Bauersachs Sports or statins for atheroprotection? New insight from Kruppel-like factor 2 Cardiovasc Res, November 1, 2006; 72(2): 193 - 195. [Full Text] [PDF]
|
|
|
|
|
|
W. Ruf Flow perturbation is linked to endothelial par signaling. Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 962 - 964. [Full Text] [PDF]
|
|